Global Radiation Therapy Market Report: 2013 Edition

Albany, NY -- (SBWire) -- 01/16/2014 --Radiotherapy is used to kill cancerous cells and is commonly used either alone or in combination with surgery or chemotherapy. From conventional radiotherapy to advanced forms of treatment such as Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT) and proton therapy have become more widely accepted methods of treatment. The radiation therapy market is growing at a healthy pace over the past few years on account of rising cancer cases and increase in sophistication of new treatment processes. Several countries with growing economies, including China, India, South Africa and Brazil, are under-equipped and offer a huge opportunity for growth. External beam therapy devices contribute the maximum share to the global radiotherapy devices market, followed by internal radiotherapy devices and systemic radiotherapy devices.

View Full Report With Complete TOC at http://www.researchmoz.us/global-radiation-therapy-market-report-2013-edition-report.html

The US market segment is relatively mature and has a significant portion of the installed capacity worldwide. The US market is largely driven by replacements of older radiotherapy systems and reimbursement levels for radiation therapy. In Europe, markets like Russia, Turkey and countries in Eastern Europe have a shortage of radiotherapy systems. Demand in Asia Pacific market remained high in the year 2012 with relatively strong growth in China and India. Key issues of the market include strict regulations and costly treatment. The medical equipment industry is characterized by rapid technological developments and continuous improvements of industrial know-how, resulting in companies launching new products and improved methods for treatment. In radiotherapy and radiosurgery markets, there are three major players namely Varian, Elekta AB and Accuray Incorporated.

This report analyzes the global radiation therapy market with focus on sub-segments like linear accelerator system, proton therapy and particle therapy. The report presents some of the major drivers, trends and challenges being faced by the industry. It also analyzes the competitive scenario of the global radiation therapy market, along with the competitive conditions being faced in North America, Europe and Asia Pacific. The profiles of the four major players, Varian, Elekta, Siemens, and Accuray are being included in the report.

Browse Other Published Reports By Koncept Analytics at http://www.researchmoz.us/publisher/koncept-analytics-24.html

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables, and tests.

Related Reports -

Gastrointestinal Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Counter Declines from Patent Expiries

View Full Report - http://www.researchmoz.us/gastrointestinal-therapeutics-in-major-developed-markets-to-2019-new-drug-approvals-and-promising-pipeline-to-counter-declines-from-patent-expiries-report.html

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis carried out by GBI Research’s team of industry experts. In 2012, the value of the gastrointestinal therapeutics market in major developed countries amounted to an estimated $6.8 billion. This total is forecast to decline at a Compound Annual Growth Rate (CAGR) of 0.3% between 2012 and 2019. The value of the IBS market amounted to an estimated $727m, and is forecast to increase at a CAGR of 14.4% between 2012 and 2019. The value of the UC market amounted to an estimated $2.2 billion in 2012, and is expected to increase at a CAGR of 6% during the forecast period. The value of the CD market amounted to an estimated $3.8 billion, which is expected to decline at a CAGR of 7.5% between 2012 and 2019.

Ophthalmology Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Trigger Shift in Treatment Paradigm to Combination Therapies

View Full Report - http://www.researchmoz.us/ophthalmology-therapeutics-in-major-developed-markets-to-2019-new-drug-approvals-and-promising-pipeline-to-trigger-shift-in-treatment-paradigm-to-combination-therapies-report.html

"Ophthalmology Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Trigger Shift in Treatment Paradigm to Combination Therapies", which provides insights into two therapeutic indications in ophthalmology in Top Eight Markets of the US, the UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an in-depth analysis of the therapeutic indications of ophthalmology, namely glaucoma and Dry Eye Syndrome (DES). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these two ophthalmology indications.

Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 - Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat

View Full Report - http://www.researchmoz.us/cardiovascular-diseases-therapeutics-in-major-developed-markets-to-2019-increasing-prevalence-and-promising-novel-drugs-offset-patent-cliff-threat-report.html

"Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 – Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat", which provides insights into three cardiovascular therapeutic indications in the top eight markets of the US, the UK, Germany, France, Italy, Spain, Japan and Canada. The report provides an in-depth analysis of the cardiovascular therapeutic indications, namely heart failure, myocardial infarction (MI), acute coronary syndrome (ACS). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these three cardiovascular indications.

Prostate Cancer Therapeutics Market to 2019 - Rising Prevalence and Strong Uptake of Recent Approvals to Drive Robust Growth to 2019

View Full Report - http://www.researchmoz.us/prostate-cancer-therapeutics-market-to-2019-rising-prevalence-and-strong-uptake-of-recent-approvals-to-drive-robust-growth-to-2019-report.html

Prostate Cancer Therapeutics Market to 2019 - Rising Prevalence and Strong Uptake of Recent Approvals to Drive Robust Growth to 2019”. The recent approval of a number of highly effective drugs, including Zytiga and Xtandi, has provided late-stage patients with a number of options and increased survival times by a number of months. These recent approvals are anticipated to generate strong revenues during the forecast following increasing uptake by physicians as the treatment algorithm shifts towards their first-line usage over Taxotere. Additionally, a very large late-stage pipeline is anticipated to produce a number of new market entrants which are superior to existing products. Overall, this is anticipated to drive rapid market growth from $4.1 billion in 2012 to $8.0 billion by 2019 at a CAGR of 10.1%.

About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:
Website@ http://www.researchmoz.us/
Email: sales@researchmoz.us
Visit: http://businessfuturetrends.blogspot.com/